Tuzun, Ahmet Yekta

Profile Picture
Profile URL
https://hdl.handle.net/20.500.14365/7506
Name Variants
AY Tüzün
AY Tuzun
Tuzun, AY
Job Title
Email Address
ahmetyekta.tuzun@mph.com.tr
ahmet.yekta@ieu.edu.tr
Main Affiliation
09.02. Internal Sciences
Status
Current Staff
Website
ORCID ID
0009-0000-7447-9710
Scopus Author ID
58597709700
Turkish CoHE Profile ID
60FB65FF4509D789
Google Scholar ID
WoS Researcher ID
JMN-2026-2023
Files
Yekta.jpeg (53.92 KB)

Sustainable Development Goals

SDG data is not available
Documents

2

Citations

1

h-index

1

Go to Scopus profile
Documents

0

Citations

0

Go to WoS profile
Scholarly Output

1

Articles

1

Views / Downloads

0/1

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

0

Scopus Citation Count

0

WoS h-index

0

Scopus h-index

0

Patents

0

Projects

0

WoS Citations per Publication

0.00

Scopus Citations per Publication

0.00

Open Access Source

1

Supervised Theses

0

Google Analytics Visitor Traffic

JournalCount
Annals of Medical Research1
Current Page: 1 / 1

Scopus Quartile Distribution

Quartile distribution chart data is not available

Competency Cloud

GCRIS Competency Cloud

Filters

20231
Reset filters

Settings

Scholarly Output Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Article
    Endoscopic Botulinium Toxin-A Application in the Treatment of Obesity: the Effect of Dose and Application Area on Treatment Success
    (2023) Özsan, İsmail; Tuzun, Ahmet Yekta
    Aim: In this study, it was aimed to examine the effect of dose and region on the effectiveness of Endoscopic botulinum toxin A application in the fight against obesity. Materials and Methods: A total of 446 patients who applied to our clinic with the complaint of weight were included in the study. Endoscopic botulinum toxin A was administered at doses of 300 U (n=74), 400 U (n=172) and 500 U (n=200) according to the weight and Body Mass Index (BMI) values of the patients. Patients were divided into three groups in the Preploric, Cardia and Fundus regions, after 125 U of Endoscopic Botulinum toxin A application to each region, and 125 U application to one region. Results: Initial BMI, weight difference, last BMI and BMI differences were statistically significant between patient groups according to dose and area (p=0.000). All BMI differences between paired dose and area groups were statistically significant (p=0.000). BMI difference was significantly correlated with gender (r=0.108; p=0.023), Initial BMI (r=0.266; p=0.000), weight (r=0.219; p=0.000), dose (r=0.834; p=0.000), and area (r=0.200; p=0.000). Effects of initial BMI (B=0.031; p=0.031), dose (B=1.423; p=0.000) and area (B=0.316; p=0.000) on BMI difference were statistically significant. Conclusion: Optimum results are obtained in the application of fundus region with a density of 500 U in total, but at levels or values below this, the results may not be effective. Weight loss with the Endoscopic botulinium toxin-A method with the appropriate dose and area is an effective and usable method in the fight against obesity.